[ARTICLE] 5 [PERIOD-TYPE] QTR-2 [FISCAL-YEAR-END] MAR-31-2001 [PERIOD-END] SEP-30-2000 [CASH] $ 2,249 [SECURITIES] 6,170 [RECEIVABLES] 8,874 [ALLOWANCES] (200) [INVENTORY] 10,496 [CURRENT-ASSETS] $ 28,638<F1> [PP&E] 32,147 [DEPRECIATION] (19,813) [TOTAL-ASSETS] $ 43,080<F2> [CURRENT-LIABILITIES] $ 7,680 [BONDS] 0 [COMMON] 57,411 [PREFERRED-MANDATORY] 0 [PREFERRED] 0 [OTHER-SE] (30,830) [TOTAL-LIABILITY-AND-EQUITY] $ 43,080 [SALES] $ 16,112 [TOTAL-REVENUES] 16,112 [CGS] 10,725 [TOTAL-COSTS] 14,482<F3> [OTHER-EXPENSES] 103<F4> [LOSS-PROVISION] 0 [INTEREST-EXPENSE] $ 483 [INCOME-PRETAX] 1,250 [INCOME-TAX] 25 [INCOME-CONTINUING] 0 [DISCONTINUED] 0 [EXTRAORDINARY] 0 [CHANGES] 0 [NET-INCOME] 1,225 [EPS-BASIC] 0.11 [EPS-DILUTED] 0.10 <FN> <F1>Includes - Other assets - $1,049K. <F2>Includes - Restricted cash - $984K; Other long term assets - $1,124K. <F3>Includes - Research and development - $900K; Selling, marketing, and administrative - $2,857K; <F4>Includes - Interest Income ($138);other expense $271K </FN>